Relation between viral fitness and immune escape within the hepatitis C virus protease

被引:87
作者
Söderholm, J
Ahlén, G
Kaul, A
Frelin, L
Alheim, M
Barnfield, C
Liljeström, P
Weiland, O
Milich, DR
Bartenschlager, R
Sällberg, M
机构
[1] Karolinska Univ Hosp Huddinge, Div Clin Virol, Karolinska Inst, Stockholm, Sweden
[2] Karolinska Univ Hosp Huddinge, Div Infect Dis, Karolinska Inst, Stockholm, Sweden
[3] Heidelberg Univ, Div Mol Virol, Heidelberg, Germany
[4] Vaccine Res Inst, San Diego, CA USA
[5] Karolinska Inst, Swedish Inst Infect Dis Control, Stockholm, Sweden
[6] Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden
关键词
D O I
10.1136/gut.2005.072231
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The hepatitis C virus (HCV) mutates within human leucocyte antigen (HLA) class I restricted immunodominant epitopes of the non-structural (NS) 3/4A protease to escape cytotoxic T lymphocyte (CTL) recognition and promote viral persistence. However, variability is not unlimited, and sometimes almost absent, and factors that restrict viral variability have not been defined experimentally. Aims: We wished to explore whether the variability of the immunodominant CTL epitope at residues 1073-1081 of the NS3 protease was limited by viral fitness. Patients: Venous blood was obtained from six patients (four HLA-A2+) with chronic HCV infection and from one HLA-A2+ patient with acute HCV infection. Methods: NS3/4A genes were amplified from serum, cloned in a eukaryotic expression plasmid, sequenced, and expressed. CTL recognition of naturally occurring and artificially introduced escape mutations in HLA-A2-restricted NS3 epitopes were determined using CTLs from human blood and genetically immunised HLA-A2-transgenic mice. HCV replicons were used to test the effect of escape mutations on HCV protease activity and RNA replication. Results: Sequence analysis of NS3/4A confirmed low genetic variability. The major viral species had functional proteases with 1073-1081 epitopes that were generally recognised by cross reactive human and murine HLA-A2 restricted CTLs. Introduction of mutations at five positions of the 1073-1081 epitope prevented CTL recognition but three of these reduced protease activity and RNA replication. Conclusions: Viral fitness can indeed limit the variability of HCV within immunological epitopes. This helps to explain why certain immunological escape variants never appear as a major viral species in infected humans.
引用
收藏
页码:266 / 274
页数:9
相关论文
共 60 条
[1]   Efficient rescue of hepatitis C virus RNA replication by trans-complementation with nonstructural protein 5A [J].
Appel, N ;
Herian, U ;
Bartenschlager, R .
JOURNAL OF VIROLOGY, 2005, 79 (02) :896-909
[2]   NONSTRUCTURAL PROTEIN-3 OF THE HEPATITIS-C VIRUS ENCODES A SERINE-TYPE PROTEINASE REQUIRED FOR CLEAVAGE AT THE NS3/4 AND NS4/5 JUNCTIONS [J].
BARTENSCHLAGER, R ;
AHLBORNLAAKE, L ;
MOUS, J ;
JACOBSEN, H .
JOURNAL OF VIROLOGY, 1993, 67 (07) :3835-3844
[3]   COMPLEX-FORMATION BETWEEN THE NS3 SERINE-TYPE PROTEINASE OF THE HEPATITIS-C VIRUS AND NS4A AND ITS IMPORTANCE FOR POLYPROTEIN MATURATION [J].
BARTENSCHLAGER, R ;
LOHMANN, V ;
WILKINSON, T ;
KOCH, JO .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7519-7528
[4]   KINETIC AND STRUCTURAL-ANALYSES OF HEPATITIS-C VIRUS POLYPROTEIN PROCESSING [J].
BARTENSCHLAGER, R ;
AHLBORNLAAKE, L ;
MOUS, J ;
JACOBSEN, H .
JOURNAL OF VIROLOGY, 1994, 68 (08) :5045-5055
[5]   Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope [J].
Brinster, C ;
Muguet, S ;
Lone, YC ;
Boucreux, D ;
Renard, N ;
Fournillier, A ;
Lemonnier, F ;
Inchauspé, G .
HEPATOLOGY, 2001, 34 (06) :1206-1217
[6]   CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HEPATITIS-C VIRUS-DERIVED PEPTIDES CONTAINING THE HLA A2.1 BINDING MOTIF [J].
CERNY, A ;
MCHUTCHISON, JG ;
PASQUINELLI, C ;
BROWN, ME ;
BROTHERS, MA ;
GRABSCHEID, B ;
FOWLER, P ;
HOUGHTON, M ;
CHISARI, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :521-530
[7]   Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus [J].
Chang, KM ;
Rehermann, B ;
McHutchison, JG ;
Pasquinelli, C ;
Southwood, S ;
Sette, A ;
Chisari, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2376-2385
[8]   Analysis of a successful immune response against hepatitis C virus [J].
Cooper, S ;
Erickson, AL ;
Adams, EJ ;
Kansopon, J ;
Weiner, AJ ;
Chien, DY ;
Houghton, M ;
Parham, P ;
Walker, CM .
IMMUNITY, 1999, 10 (04) :439-449
[9]   Cellular immune selection with hepatitis C virus persistence in humans [J].
Cox, AL ;
Mosbruger, T ;
Mao, Q ;
Liu, Z ;
Wang, XH ;
Yang, HC ;
Sidney, J ;
Sette, A ;
Pardoll, D ;
Thomas, DL ;
Ray, SC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (11) :1741-1752
[10]   Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection [J].
Cucchiarini, M ;
Kammer, AR ;
Grabscheid, B ;
Diepolder, HM ;
Gerlach, TJ ;
Grüner, N ;
Santantonio, T ;
Reichen, J ;
Pape, GR ;
Cerny, A .
CELLULAR IMMUNOLOGY, 2000, 203 (02) :111-123